Tuesday, 13th November Clinical Oncology Society of Australia Annual Scientific Meeting 2018

7:00AM - 5:30PM
Tuesday, 13th November
Level 2 Registration Desk
7:15AM - 8:15AM
Tuesday, 13th November
Meeting Room 3

Improvement and implementation sciences are increasingly recognised as critical to ensuring quality of cancer care and timely adoption of best evidence into clinical practice. Research funding bodies require that research proposals consider how research findings will be translated into practice making knowledge of improvement and implementation necessary for both research and practice. This session will outline fundamental concepts of improvement science and implementation science and explore how they can be utilised in clinical practice to improve outcomes and increase value and how they can strengthen research applications to make them more competitive.

Chair: Bogda Koczwara 
Speakers: Bogda Koczwara, Christine Paul

This breakfast session is supported by COSA 

COSA1530668373.jpg



7:15AM - 8:15AM
Tuesday, 13th November
River View Room 4

Family caregivers regularly attend consultations as patients’ supporters / advocates and often provide unpaid, personalised care to cancer patients. When informed and empowered, family caregivers can be valuable partners in cancer care. However, research shows that oncology clinicians do not always meaningfully engage with family caregivers. Also, some family members can introduce challenges, such as if they dominate the patient, request private patient information, disagree with the patient’s treatment wishes, or display anger towards staff. Building a positive working relationship with family caregivers and managing these challenges requires confidence and skill.

The TRIO Guidelines for communicating with family caregivers provide clear, specific, and evidence-based recommendations for oncology health professionals interacting with a patient’s family.

This session will provide an overview of the TRIO Guidelines, and will highlight specific behaviours and phrases clinicians can use to build a productive relationship with their patients’ family caregivers.

Professionally produced short films will be featured, which demonstrate skills from the TRIO Guidelines used in common clinical scenarios. Attendees will be provided with a hardcopy booklet of the TRIO Guidelines.

Oncology health professionals, researchers, and consumers are invited to attend the TRIO Guidelines breakfast launch.

Chair: Christobel Saunders 
Speakers: Ilona Juraskova, Phyllis Butow, Rebekah Laidsaar-Powell 

This breakfast session is supported by COSA 

COSA1530668373.jpg

8:30AM - 9:00AM
Tuesday, 13th November
Riverside Theatre
Chair: Phyllis Butow

Welcome by COSA President

Welcome to Country by local indigenous group

10:30AM - 11:00AM
Tuesday, 13th November
Pavilion 1 (Exhibition Area)
11:00AM - 12:30PM
Tuesday, 13th November
River View Room 5
Chair: Yvonne Zissiadis

Panel discussion at the end

12:30PM - 1:30PM
Tuesday, 13th November
Pavilion 1 (Exhibition Area)
Sponsored by:
12:30PM - 1:30PM
Tuesday, 13th November
Meeting Room 1 & 2
12:30PM - 1:30PM
Tuesday, 13th November
Meeting Room 3
12:30PM - 1:30PM
Tuesday, 13th November
River View Room 4
12:30PM - 1:30PM
Tuesday, 13th November
River View Room 5
12:30PM - 1:30PM
Tuesday, 13th November
Riverside Theatre
3:00PM - 4:00PM
Tuesday, 13th November
Pavilion 1 (Exhibition Area)
Sponsored by:
3:00PM - 4:00PM
Tuesday, 13th November
Pavilion 1 (Exhibition Area)
5:30PM - 6:30PM
Tuesday, 13th November
Meeting Room 3
5:30PM - 7:00PM
Tuesday, 13th November
Pavilion 1 (Exhibition Area)
7:00PM - 8:30PM
Tuesday, 13th November
River View Room 5
Sponsored by:

Genomics is facilitating a deeper understanding of cancer biology and through clinical research, new biomarkers are emerging that pave the way for next-generation therapeutics to help fight cancer in a more personalized way. Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early phase clinical trials involving immunotherapy across all types of cancer. Dr. Patel is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He believes in offering these promising immunotherapeutics across all tumor types.

Chair: Libby Thomas, MD Illumina Australia Pty Ltd Sales Specialist

Speakers: Sandip P. Patel, MD Medical Oncologist Assistant Professor of Medicine US San Diego Health